These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33829071)

  • 1. CBCT-Based Adaptive Assessment Workflow for Intensity Modulated Proton Therapy for Head and Neck Cancer.
    De Ornelas M; Xu Y; Padgett K; Schmidt RM; Butkus M; Diwanji T; Luciani G; Lambiase J; Samuels S; Samuels M; Dogan N
    Int J Part Ther; 2021; 7(4):29-41. PubMed ID: 33829071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cone beam CT-based adaptive intensity modulated proton therapy assessment using automated planning for head-and-neck cancer.
    Xu Y; Jin W; Butkus M; De Ornelas M; Cyriac J; Studenski MT; Padgett K; Simpson G; Samuels S; Samuels M; Dogan N
    Radiat Oncol; 2024 Jan; 19(1):13. PubMed ID: 38263237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of daily dose accumulation for robustly optimized intensity modulated proton therapy treatment of prostate cancer.
    Xu Y; Diwanji T; Brovold N; Butkus M; Padgett KR; Schmidt RM; King A; Dal Pra A; Abramowitz M; Pollack A; Dogan N
    Phys Med; 2021 Jan; 81():77-85. PubMed ID: 33445124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of automated proton therapy plan adaptation for head and neck tumors using cone beam CT images.
    Kurz C; Nijhuis R; Reiner M; Ganswindt U; Thieke C; Belka C; Parodi K; Landry G
    Radiat Oncol; 2016 Apr; 11():64. PubMed ID: 27129305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technical note: Evaluation of deep learning based synthetic CTs clinical readiness for dose and NTCP driven head and neck adaptive proton therapy.
    de Koster RJC; Thummerer A; Scandurra D; Langendijk JA; Both S
    Med Phys; 2023 Dec; 50(12):8023-8033. PubMed ID: 37831597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric evaluation of cone-beam CT-based synthetic CTs in pediatric patients undergoing intensity-modulated proton therapy.
    Sheikh K; Liu D; Li H; Acharya S; Ladra MM; Hrinivich WT
    J Appl Clin Med Phys; 2022 Jun; 23(6):e13604. PubMed ID: 35413144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers.
    Liu W; Frank SJ; Li X; Li Y; Park PC; Dong L; Ronald Zhu X; Mohan R
    Med Phys; 2013 May; 40(5):051711. PubMed ID: 23635259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose uncertainties in IMPT for oropharyngeal cancer in the presence of anatomical, range, and setup errors.
    Kraan AC; van de Water S; Teguh DN; Al-Mamgani A; Madden T; Kooy HM; Heijmen BJ; Hoogeman MS
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):888-96. PubMed ID: 24351409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical evaluation of worst-case robust optimization intensity-modulated proton therapy plans using an exhaustive sampling approach.
    Yang Z; Li H; Li Y; Li Y; Chang Y; Li Q; Yang K; Wu G; Sahoo N; Poenisch F; Gillin M; Zhu XR; Zhang X
    Radiat Oncol; 2019 Jul; 14(1):129. PubMed ID: 31324257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of MRI-only treatment planning for proton therapy in brain and prostate cancers: Dose calculation accuracy in substitute CT images.
    Koivula L; Wee L; Korhonen J
    Med Phys; 2016 Aug; 43(8):4634. PubMed ID: 27487880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of linear and nonlinear programming approaches for "worst case dose" and "minmax" robust optimization of intensity-modulated proton therapy dose distributions.
    Zaghian M; Cao W; Liu W; Kardar L; Randeniya S; Mohan R; Lim G
    J Appl Clin Med Phys; 2017 Mar; 18(2):15-25. PubMed ID: 28300378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
    Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W
    Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Pilot Study on the Comparison between Planning Target Volume-based Intensity-Modulated Proton Therapy Plans and Robustly Optimized Intensity-Modulated Proton Therapy Plans.
    Perumal B; Sundaresan HE; Vaitheeswaran R
    J Med Phys; 2018; 43(3):179-184. PubMed ID: 30305776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of weekly and daily online adaptation for head and neck intensity-modulated proton therapy.
    Bobić M; Lalonde A; Sharp GC; Grassberger C; Verburg JM; Winey BA; Lomax AJ; Paganetti H
    Phys Med Biol; 2021 Feb; 66(5):. PubMed ID: 33503592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scatter correction of 4D cone beam computed tomography to detect dosimetric effects due to anatomical changes in proton therapy for lung cancer.
    Schmitz H; Rabe M; Janssens G; Rit S; Parodi K; Belka C; Kamp F; Landry G; Kurz C
    Med Phys; 2023 Aug; 50(8):4981-4992. PubMed ID: 36847184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the effect of setup uncertainty reduction and adaptation to geometric changes on normal tissue complication probability using online adaptive head and neck intensity modulated proton therapy.
    Lalonde A; Bobić M; Sharp GC; Chamseddine I; Winey B; Paganetti H
    Phys Med Biol; 2023 May; 68(11):. PubMed ID: 37164020
    [No Abstract]   [Full Text] [Related]  

  • 17. Large anatomical changes in head-and-neck cancers - A dosimetric comparison of online and offline adaptive proton therapy.
    Bobić M; Lalonde A; Nesteruk KP; Lee H; Nenoff L; Gorissen BL; Bertolet A; Busse PM; Chan AW; Winey BA; Sharp GC; Verburg JM; Lomax AJ; Paganetti H
    Clin Transl Radiat Oncol; 2023 May; 40():100625. PubMed ID: 37090849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating CT to CBCT image registration for head and neck proton therapy as a tool for daily dose recalculation.
    Landry G; Nijhuis R; Dedes G; Handrack J; Thieke C; Janssens G; Orban de Xivry J; Reiner M; Kamp F; Wilkens JJ; Paganelli C; Riboldi M; Baroni G; Ganswindt U; Belka C; Parodi K
    Med Phys; 2015 Mar; 42(3):1354-66. PubMed ID: 25735290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential proton and photon dose degradation in advanced head and neck cancer patients by intratherapy changes.
    Stützer K; Jakobi A; Bandurska-Luque A; Barczyk S; Arnsmeyer C; Löck S; Richter C
    J Appl Clin Med Phys; 2017 Nov; 18(6):104-113. PubMed ID: 28921843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robust optimization in intensity-modulated proton therapy to account for anatomy changes in lung cancer patients.
    Li H; Zhang X; Park P; Liu W; Chang J; Liao Z; Frank S; Li Y; Poenisch F; Mohan R; Gillin M; Zhu R
    Radiother Oncol; 2015 Mar; 114(3):367-72. PubMed ID: 25708992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.